next quarter could easily see the $1 sp hit if we get some traction in Europe with the flu kit . That might put GSS into a cash flow positive situation as well . More Aust and EU approvals expected this year will only drive the share price and guarantee a decent capital base for the company .
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
GSS
genetic signatures limited
Add to My Watchlist
0.00%
!
37.0¢

next quarter could easily see the $1 sp hit if we get some...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.04M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 37.0¢ | $740 | 2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27000 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27000 | 0.370 |
1 | 10000 | 0.365 |
3 | 8407 | 0.360 |
1 | 40000 | 0.355 |
4 | 130509 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
0.480 | 500 | 1 |
Last trade - 10.00am 15/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online